Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis

Purpose: To report two cases of catastrophic retinal vascular occlusion and crystalline retinopathy due to presumed oxalosis and hyperphosphatemia. Observations: We describe two unrelated patients with end-stage kidney failure (ESKD) treated with peritoneal dialysis that developed rapid bilateral vi...

Full description

Saved in:
Bibliographic Details
Main Authors: Delu Song, Charles Ginsberg, Eric Nudleman, Shyamanga Borooah, Andrew King, Elodie Bousquet, David Sarraf, Michael Goldbaum
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993624001634
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850113652021002240
author Delu Song
Charles Ginsberg
Eric Nudleman
Shyamanga Borooah
Andrew King
Elodie Bousquet
David Sarraf
Michael Goldbaum
author_facet Delu Song
Charles Ginsberg
Eric Nudleman
Shyamanga Borooah
Andrew King
Elodie Bousquet
David Sarraf
Michael Goldbaum
author_sort Delu Song
collection DOAJ
description Purpose: To report two cases of catastrophic retinal vascular occlusion and crystalline retinopathy due to presumed oxalosis and hyperphosphatemia. Observations: We describe two unrelated patients with end-stage kidney failure (ESKD) treated with peritoneal dialysis that developed rapid bilateral vision loss due to severe retinal vascular occlusion. Multi-modal retinal imaging studies demonstrated crystalline deposits. Plasma phosphorus and oxalate levels were markedly elevated compared to persons with normal kidney function. One patient harbored a heterozygous variant of unknown significance in the Alanine--Glyoxylate Aminotransferase (AGXT) gene. Intense hemodialysis and diet modification reduced phosphorus and oxalate levels. Conclusions and importance: This report serves to raise awareness of hyperphosphatemia and oxalosis in dialysis patients to alert providers so that they can act to decrease the potential risk of vision loss.
format Article
id doaj-art-9db1cd38b42948e5afdafa9a05116921
institution OA Journals
issn 2451-9936
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series American Journal of Ophthalmology Case Reports
spelling doaj-art-9db1cd38b42948e5afdafa9a051169212025-08-20T02:37:05ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362024-12-013610215310.1016/j.ajoc.2024.102153Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysisDelu Song0Charles Ginsberg1Eric Nudleman2Shyamanga Borooah3Andrew King4Elodie Bousquet5David Sarraf6Michael Goldbaum7Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, CA, USA; San Diego Retina Associates, San Diego, CA, USA; Corresponding author. Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, University of California at San Diego, USA.Division of Nephrology-Hypertension, UC San Diego, La Jolla, CA, USAShiley Eye Institute, The Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, CA, USAShiley Eye Institute, The Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, CA, USADepartment of Nephrology, Scripps Clinic, La Jolla, CA, USAStein Eye Institute, UC Los Angeles, Los Angeles, CA, USAStein Eye Institute, UC Los Angeles, Los Angeles, CA, USAShiley Eye Institute, The Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, CA, USA; Corresponding author. Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, University of California at San Diego, USA.Purpose: To report two cases of catastrophic retinal vascular occlusion and crystalline retinopathy due to presumed oxalosis and hyperphosphatemia. Observations: We describe two unrelated patients with end-stage kidney failure (ESKD) treated with peritoneal dialysis that developed rapid bilateral vision loss due to severe retinal vascular occlusion. Multi-modal retinal imaging studies demonstrated crystalline deposits. Plasma phosphorus and oxalate levels were markedly elevated compared to persons with normal kidney function. One patient harbored a heterozygous variant of unknown significance in the Alanine--Glyoxylate Aminotransferase (AGXT) gene. Intense hemodialysis and diet modification reduced phosphorus and oxalate levels. Conclusions and importance: This report serves to raise awareness of hyperphosphatemia and oxalosis in dialysis patients to alert providers so that they can act to decrease the potential risk of vision loss.http://www.sciencedirect.com/science/article/pii/S2451993624001634Crystalline retinopathyOxalatePhosphorusOcclusive retinopathyVision loss
spellingShingle Delu Song
Charles Ginsberg
Eric Nudleman
Shyamanga Borooah
Andrew King
Elodie Bousquet
David Sarraf
Michael Goldbaum
Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis
American Journal of Ophthalmology Case Reports
Crystalline retinopathy
Oxalate
Phosphorus
Occlusive retinopathy
Vision loss
title Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis
title_full Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis
title_fullStr Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis
title_full_unstemmed Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis
title_short Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis
title_sort catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end stage kidney disease treated with peritoneal dialysis
topic Crystalline retinopathy
Oxalate
Phosphorus
Occlusive retinopathy
Vision loss
url http://www.sciencedirect.com/science/article/pii/S2451993624001634
work_keys_str_mv AT delusong catastrophicretinalvascularocclusionandvisionlossduetocrystaldepositioninendstagekidneydiseasetreatedwithperitonealdialysis
AT charlesginsberg catastrophicretinalvascularocclusionandvisionlossduetocrystaldepositioninendstagekidneydiseasetreatedwithperitonealdialysis
AT ericnudleman catastrophicretinalvascularocclusionandvisionlossduetocrystaldepositioninendstagekidneydiseasetreatedwithperitonealdialysis
AT shyamangaborooah catastrophicretinalvascularocclusionandvisionlossduetocrystaldepositioninendstagekidneydiseasetreatedwithperitonealdialysis
AT andrewking catastrophicretinalvascularocclusionandvisionlossduetocrystaldepositioninendstagekidneydiseasetreatedwithperitonealdialysis
AT elodiebousquet catastrophicretinalvascularocclusionandvisionlossduetocrystaldepositioninendstagekidneydiseasetreatedwithperitonealdialysis
AT davidsarraf catastrophicretinalvascularocclusionandvisionlossduetocrystaldepositioninendstagekidneydiseasetreatedwithperitonealdialysis
AT michaelgoldbaum catastrophicretinalvascularocclusionandvisionlossduetocrystaldepositioninendstagekidneydiseasetreatedwithperitonealdialysis